PMS2

Gene

Related News

Genetic biomarker tests shift colorectal cancer screening toward DNA changes in India

Apr 06, 2026

Recent advances in genetic science are shifting colorectal cancer screening toward direct detection of DNA changes. In India, CRC is now the fourth most common cancer, with more than 64,000 new cases and over 38,000 deaths reported in 2022.

Lynch Syndrome Testing, Immunotherapy, and Cancer Vaccine Advances in 2026

Feb 26, 2026

Lynch syndrome patients gain access to prevention vaccines in clinical trials, while immunotherapy advances depend on universal tumor testing for microsatellite instability. Cancer vaccines are moving from research to clinical reality.